Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

The association of microhematuria with mesangial hypercellularity, endocapillary hypercellularity, crescent score and renal outcomes in immunoglobulin A nephropathy.

Bobart SA, Alexander MP, Shawwa K, Vaughan LE, Ghamrawi R, Sethi S, Cornell L, Glassock RJ, Fervenza FC, Zand L.

Nephrol Dial Transplant. 2019 Dec 20. pii: gfz267. doi: 10.1093/ndt/gfz267. [Epub ahead of print]

PMID:
31859353
2.

Bacterial Cholangitis in Autosomal Dominant Polycystic Kidney and Liver Disease.

Martin WP, Vaughan LE, Yoshida K, Takahashi N, Edwards ME, Metzger A, Senum SR, Masyuk TV, LaRusso NF, Griffin MD, El-Zoghby Z, Harris PC, Kremers WK, Nagorney DM, Kamath PS, Torres VE, Hogan MC.

Mayo Clin Proc Innov Qual Outcomes. 2019 May 27;3(2):149-159. doi: 10.1016/j.mayocpiqo.2019.03.004. eCollection 2019 Jun.

3.

Vaginal bromocriptine improves pain, menstrual bleeding and quality of life in women with adenomyosis: A pilot study.

Andersson JK, Khan Z, Weaver AL, Vaughan LE, Gemzell-Danielsson K, Stewart EA.

Acta Obstet Gynecol Scand. 2019 Oct;98(10):1341-1350. doi: 10.1111/aogs.13632. Epub 2019 Jun 14.

PMID:
31025313
4.

Vaginal Diazepam for Nonrelaxing Pelvic Floor Dysfunction: The Pharmacokinetic Profile.

Larish AM, Dickson RR, Kudgus RA, McGovern RM, Reid JM, Hooten WM, Nicholson WT, Vaughan LE, Burnett TL, Laughlin-Tommaso SK, Faubion SS, Green IC.

J Sex Med. 2019 Jun;16(6):763-766. doi: 10.1016/j.jsxm.2019.03.003. Epub 2019 Apr 19.

PMID:
31010782
5.

FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery.

Laughlin-Tommaso S, Barnard EP, AbdElmagied AM, Vaughan LE, Weaver AL, Hesley GK, Woodrum DA, Jacoby VL, Kohi MP, Price TM, Nieves A, Miller MJ, Borah BJ, Moriarty JP, Gorny KR, Leppert PC, Severson AL, Lemens MA, Stewart EA.

Am J Obstet Gynecol. 2019 Feb;220(2):174.e1-174.e13. doi: 10.1016/j.ajog.2018.10.032. Epub 2018 Oct 26.

6.

Larger nephron size, low nephron number, and nephrosclerosis on biopsy as predictors of kidney function after donating a kidney.

Issa N, Vaughan LE, Denic A, Kremers WK, Chakkera HA, Park WD, Matas AJ, Taler SJ, Stegall MD, Augustine JJ, Rule AD.

Am J Transplant. 2019 Jul;19(7):1989-1998. doi: 10.1111/ajt.15259. Epub 2019 Feb 1.

PMID:
30629312
7.

A mathematical model of neuroinflammation in severe clinical traumatic brain injury.

Vaughan LE, Ranganathan PR, Kumar RG, Wagner AK, Rubin JE.

J Neuroinflammation. 2018 Dec 18;15(1):345. doi: 10.1186/s12974-018-1384-1.

8.

Electronic Algorithm Is Superior to Hospital Discharge Codes for Diagnoses of Hypertensive Disorders of Pregnancy in Historical Cohorts.

Milic NM, Codsi E, Butler Tobah YS, White WM, Kattah AG, Weissgerber TL, Saiki M, Parashuram S, Vaughan LE, Weaver AL, Savic M, Mielke MM, Garovic VD.

Mayo Clin Proc. 2018 Dec;93(12):1707-1719. doi: 10.1016/j.mayocp.2018.08.031.

9.

Predictors of Symptomatic Kidney Stone Recurrence After the First and Subsequent Episodes.

Vaughan LE, Enders FT, Lieske JC, Pais VM, Rivera ME, Mehta RA, Vrtiska TJ, Rule AD.

Mayo Clin Proc. 2019 Feb;94(2):202-210. doi: 10.1016/j.mayocp.2018.09.016. Epub 2018 Dec 4.

10.

Risk of ESRD and Mortality in Kidney and Bladder Stone Formers.

Dhondup T, Kittanamongkolchai W, Vaughan LE, Mehta RA, Chhina JK, Enders FT, Hickson LJ, Lieske JC, Rule AD.

Am J Kidney Dis. 2018 Dec;72(6):790-797. doi: 10.1053/j.ajkd.2018.06.012. Epub 2018 Aug 23.

11.

End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy.

Chen JC, Thorsteinsdottir B, Vaughan LE, Feely MA, Albright RC, Onuigbo M, Norby SM, Gossett CL, D'Uscio MM, Williams AW, Dillon JJ, Hickson LJ.

Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1172-1179. doi: 10.2215/CJN.00590118. Epub 2018 Jul 19.

12.

Impact of a History of Hypertension in Pregnancy on Later Diagnosis of Atrial Fibrillation.

Scantlebury DC, Kattah AG, Weissgerber TL, Agarwal S, Mielke MM, Weaver AL, Vaughan LE, Henkin S, Zimmerman K, Miller VM, White WM, Hayes SN, Garovic VD.

J Am Heart Assoc. 2018 May 13;7(10). pii: e007584. doi: 10.1161/JAHA.117.007584.

13.

Younger Adults Initiating Hemodialysis: Antidepressant Use for Depression Associated With Higher Health Care Utilization.

Vork DL, Schneekloth TD, Bartley AC, Vaughan LE, Lapid MI, Jowsey-Gregoire SG, El-Zoghby ZM, Herrmann SM, Tran CL, Albright RC, Hickson LJ.

Mayo Clin Proc. 2018 Mar;93(3):321-332. doi: 10.1016/j.mayocp.2017.12.008.

14.

The Changing Incidence and Presentation of Urinary Stones Over 3 Decades.

Kittanamongkolchai W, Vaughan LE, Enders FT, Dhondup T, Mehta RA, Krambeck AE, McCollough CH, Vrtiska TJ, Lieske JC, Rule AD.

Mayo Clin Proc. 2018 Mar;93(3):291-299. doi: 10.1016/j.mayocp.2017.11.018. Epub 2018 Feb 14.

15.

Plasma oxalate in relation to eGFR in patients with primary hyperoxaluria, enteric hyperoxaluria and urinary stone disease.

Perinpam M, Enders FT, Mara KC, Vaughan LE, Mehta RA, Voskoboev N, Milliner DS, Lieske JC.

Clin Biochem. 2017 Dec;50(18):1014-1019. doi: 10.1016/j.clinbiochem.2017.07.017. Epub 2017 Jul 29.

16.

Risk of Hypertension among First-Time Symptomatic Kidney Stone Formers.

Kittanamongkolchai W, Mara KC, Mehta RA, Vaughan LE, Denic A, Knoedler JJ, Enders FT, Lieske JC, Rule AD.

Clin J Am Soc Nephrol. 2017 Mar 7;12(3):476-482. doi: 10.2215/CJN.06600616. Epub 2017 Feb 1.

17.

Periprocedural outcomes comparing fibroid embolization and focused ultrasound: a randomized controlled trial and comprehensive cohort analysis.

Barnard EP, AbdElmagied AM, Vaughan LE, Weaver AL, Laughlin-Tommaso SK, Hesley GK, Woodrum DA, Jacoby VL, Kohi MP, Price TM, Nieves A, Miller MJ, Borah BJ, Gorny KR, Leppert PC, Peterson LG, Stewart EA.

Am J Obstet Gynecol. 2017 May;216(5):500.e1-500.e11. doi: 10.1016/j.ajog.2016.12.177. Epub 2017 Jan 5.

18.

Kidney Function After the First Kidney Stone Event.

Haley WE, Enders FT, Vaughan LE, Mehta RA, Thoman ME, Vrtiska TJ, Krambeck AE, Lieske JC, Rule AD.

Mayo Clin Proc. 2016 Dec;91(12):1744-1752. doi: 10.1016/j.mayocp.2016.08.014. Epub 2016 Oct 21.

19.

Quantitative Prediction of Stone Fragility From Routine Dual Energy CT: Ex vivo proof of Feasibility.

Ferrero A, Montoya JC, Vaughan LE, Huang AE, McKeag IO, Enders FT, Williams JC Jr, McCollough CH.

Acad Radiol. 2016 Dec;23(12):1545-1552. doi: 10.1016/j.acra.2016.07.016. Epub 2016 Oct 4.

20.

Preeclampsia and ESRD: The Role of Shared Risk Factors.

Kattah AG, Scantlebury DC, Agarwal S, Mielke MM, Rocca WA, Weaver AL, Vaughan LE, Miller VM, Weissgerber TL, White W, Garovic VD.

Am J Kidney Dis. 2017 Apr;69(4):498-505. doi: 10.1053/j.ajkd.2016.07.034. Epub 2016 Oct 1.

21.

Glomerular Pathology in Dent Disease and Its Association with Kidney Function.

Wang X, Anglani F, Beara-Lasic L, Mehta AJ, Vaughan LE, Herrera Hernandez L, Cogal A, Scheinman SJ, Ariceta G, Isom R, Copelovitch L, Enders FT, Del Prete D, Vezzoli G, Paglialonga F, Harris PC, Lieske JC; Investigators of the Rare Kidney Stone Consortium.

Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2168-2176. Epub 2016 Oct 3.

22.

Aspirin use and the incidence of breast, colon, ovarian, and pancreatic cancers in elderly women in the Iowa Women's Health Study.

Vaughan LE, Prizment A, Blair CK, Thomas W, Anderson KE.

Cancer Causes Control. 2016 Nov;27(11):1395-1402. Epub 2016 Sep 27.

23.

Correlation of Behavioral Interviewing Performance With Obstetrics and Gynecology Residency Applicant Characteristics☆?>.

Breitkopf DM, Vaughan LE, Hopkins MR.

J Surg Educ. 2016 Nov - Dec;73(6):954-958. doi: 10.1016/j.jsurg.2016.05.015. Epub 2016 Jun 16.

PMID:
27321984
24.

Fibroid interventions: reducing symptoms today and tomorrow: extending generalizability by using a comprehensive cohort design with a randomized controlled trial.

AbdElmagied AM, Vaughan LE, Weaver AL, Laughlin-Tommaso SK, Hesley GK, Woodrum DA, Jacoby VL, Kohi MP, Price TM, Nieves A, Miller MJ, Borah BJ, Gorny KR, Leppert PC, Lemens MA, Stewart EA.

Am J Obstet Gynecol. 2016 Sep;215(3):338.e1-338.e18. doi: 10.1016/j.ajog.2016.04.001. Epub 2016 Apr 9.

25.

Endoscopic and Pathologic Characterization of Papillary Architecture in Struvite Stone Formers.

Jaeger CD, Rule AD, Mehta RA, Vaughan LE, Vrtiska TJ, Holmes DR 3rd, McCollough CM, Ziegelmann MJ, Herrera Hernandez LP, Lieske JC, Krambeck AE.

Urology. 2016 Apr;90:39-44. doi: 10.1016/j.urology.2015.12.037. Epub 2016 Jan 6.

26.

Predictors of Incident ESRD among Patients with Primary Hyperoxaluria Presenting Prior to Kidney Failure.

Zhao F, Bergstralh EJ, Mehta RA, Vaughan LE, Olson JB, Seide BM, Meek AM, Cogal AG, Lieske JC, Milliner DS; Investigators of Rare Kidney Stone Consortium.

Clin J Am Soc Nephrol. 2016 Jan 7;11(1):119-26. doi: 10.2215/CJN.02810315. Epub 2015 Dec 10.

27.

Stone Composition Among First-Time Symptomatic Kidney Stone Formers in the Community.

Singh P, Enders FT, Vaughan LE, Bergstralh EJ, Knoedler JJ, Krambeck AE, Lieske JC, Rule AD.

Mayo Clin Proc. 2015 Oct;90(10):1356-65. doi: 10.1016/j.mayocp.2015.07.016. Epub 2015 Sep 6.

28.

Efficacy of 4 Years of Octreotide Long-Acting Release Therapy in Patients With Severe Polycystic Liver Disease.

Hogan MC, Masyuk T, Bergstralh E, Li B, Kremers WK, Vaughan LE, Ihrke A, Severson AL, Irazabal MV, Glockner J, LaRusso NF, Torres VE.

Mayo Clin Proc. 2015 Aug;90(8):1030-7. doi: 10.1016/j.mayocp.2015.05.011. Epub 2015 Jul 9.

29.

Endoscopic and histologic findings in a cohort of uric acid and calcium oxalate stone formers.

Viers BR, Lieske JC, Vrtiska TJ, Herrera Hernandez LP, Vaughan LE, Mehta RA, Bergstralh EJ, Rule AD, Holmes DR 3rd, Krambeck AE.

Urology. 2015 Apr;85(4):771-6. doi: 10.1016/j.urology.2014.12.036. Epub 2015 Feb 11.

Supplemental Content

Loading ...
Support Center